Navigation Links
Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
Date:7/9/2008

eviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the therapeutic range of APD791 and the exposures which may produce minimal, moderate or near-complete inhibition of serotonin-mediated amplification of platelet aggregation; the potential for APD791 to provide advantages over currently available therapies; determination of the best approach to advance APD791 into Phase 2 clinical trials; the tolerability, side effects and efficacy of APD791; the role of serotonin in thrombosis and in increasing cardiovascular risk; how APD791 is believed to work and its intended use and therapeutic potential; and about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, Arena's planned clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of preclinical studies or clinical trials may not be predictive of future results, Arena's ability to partner lorcaserin, APD125, APD791 or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents, and the timing and receipt of payments and fees, if any, from Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings w
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
2. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
3. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
6. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
7. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
8. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
9. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
10. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
11. Isis Pharmaceuticals Conference Call Notice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... COLORADO SPRINGS, Colo. , July 31, 2014 ... Company specializing in cannabis formulation-based drug development and ... has commenced production of multiple strains of cannabis ... scientific research to select the best strains for ... to bring the cannabis formulations to market for ...
(Date:7/31/2014)... , July 31, 2014 For the ... can watch the implantation of the SynCardia temporary Total ... and matching video posted on the Journal of Visualized ... and read the paper on the SynCardia Total Artificial ... 16-minute video accompanies "Implantation of the SynCardia Total Artificial ...
(Date:7/31/2014)... NEW YORK , July 31, 2014 /PRNewswire-USNewswire/ ... of discovering and developing better, faster and affordable ... as Senior Vice President, External Affairs. Mr. ... served as Head of Major Donor Relations for ... Fund). In his role, Mr. Brock will guide ...
Breaking Medicine Technology:Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2
... , NEW ... new market research report is available in its ... Global Market Review , http://www.reportlinker.com/p0164324/Holter-Monitoring-Systems---A-Global-Market-Review.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire ... is extremely beneficial for cardiac patients. High-risk patients ...
... , BIRMINGHAM, ... University of Alabama at Birmingham (UAB), and Southern Research Institute ... their collective innovation and enabling technologies in the areas of ... U.S.-India arbitraged and leveraged partnership that will accelerate the development ...
Cached Medicine Technology:Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5Reportlinker Adds Holter Monitoring Systems - A Global Market Review 6Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4
(Date:7/31/2014)... Dr. Mohebi was asked about his experience ... of traveling and sharing what we learned through research ... We are now witnessing results that we never thought ... pleasure to communicate this knowledge to our international colleagues.” ... performing FUE transplantation helped inspire many other doctors to ...
(Date:7/31/2014)... 2014 A program for anyone looking ... the University of Colorado Anschutz Health and Wellness ... boot camp and transformation program. , “Extreme Weight ... Eyeworks USA, is an evidenced-based program inspired by the ... Eyeworks USA. This season, the show has participants spending ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Current residents ... abuse treatment program in Flagstaff, AZ, learn to kayak ... of equipment and paddle strokes in preparation for next ... , "I think that [the kayaking course] teaches [residents] ... they struggle with in their early part of their ...
(Date:7/31/2014)... July 31, 2014 Parker Waichman, LLP, ... tam cases, comments that whistleblowers are a critical component ... employer activities that may cause harm to consumers and ... National Whistleblower Appreciation Day. , According to a 2013 ... the Senate declared "National Whistleblower Appreciation Day" on July ...
(Date:7/31/2014)... To further educate the public, The ... following safety information regarding leaving children in hot vehicles: ... deadly consequences. Because a child’s body can heat up ... leaving children alone in a hot vehicle puts them ... , Statistics of Children Left Alone in a Car ...
Breaking Medicine News(10 mins):Health News:Los Angles Hair Transplant Surgeon, Dr. Parsa Mohebi Inspires Doctors at Global Conferences to Adopt His Novel Method in FUE Hair Transplantation 2Health News:"Extreme Weight Loss: Destination Boot Camp" Comes to Colorado - The CU Anschutz Health and Wellness Center Begins Transformational Program 2Health News:"Extreme Weight Loss: Destination Boot Camp" Comes to Colorado - The CU Anschutz Health and Wellness Center Begins Transformational Program 3Health News:Back2Basics Substance Abuse Residents Take Kayaking Class for the First Time 2Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 2Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 3Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 4Health News:The Rothenberg Law Firm LLP Teams Up with Local Philadelphia TV Stations to Promote Awareness of the Dangers of Leaving Children Unattended in a Hot Vehicle 2Health News:The Rothenberg Law Firm LLP Teams Up with Local Philadelphia TV Stations to Promote Awareness of the Dangers of Leaving Children Unattended in a Hot Vehicle 3
... to announce the opening of its first healthcare center ... The new center opened,January 23, 2008. A second center ... Dr. Thomas Gibbons, the Midlands and Pee Dee ... excited to provide convenient,urgent care, family care and occupational ...
... Smaller Hospitals; Communities Come Out in Droves ... Jan. 25 Drum roll, please... The winner,of ... Memorial Hospital in,Lockport, N.Y. The hospital is the ... of Siemens, latest developments in magnetic resonance,imaging (MRI) ...
... Arizona, raises MDS capacity in the ... Phoenix-area to 420 total beds, KING ... ), a leading provider of innovative drug discovery,and development solutions, has ... I facility in nearby Tempe, Arizona. The $25,million facility more than ...
... Veterinarians,recently took to Capitol Hill to help ... its food supply -- and its capacity for ... needs federal support., Dr. W. Ron DeHaven, ... was one of four veterinarians to testify January ...
... GERMANTOWN, Md., Jan. 25 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: ... and commercializing novel anti-infective products, today,announced that it ... for the private placement of 8,750,000 shares of,its ... also includes,five-year warrants to purchase 3,500,000 shares of ...
... 25 Arthur Patrick Partners, a Las Vegas,private ... definitive agreement,to acquire a majority stake in Fit ... e-commerce site FitFuel.com, a retailer of healthy living,products. ... Fuel-branded,media-capable "healthy" vending machines, and has recently introduced ...
Cached Medicine News:Health News:UCI Medical Affiliates Inc. Opens New Doctors Care Center in Florence 2Health News:...And the Grand Prize Goes to... Lockport Memorial Hospital, Winner of Siemens National 'Win an MRI' Contest 2Health News:...And the Grand Prize Goes to... Lockport Memorial Hospital, Winner of Siemens National 'Win an MRI' Contest 3Health News:MDS Pharma Services Opens Largest Phase I Clinic on U.S. West Coast 2Health News:Calling for More Veterinarians 2Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 2Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 3Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 4Health News:Arthur Patrick Partners Acquires Fit Fuel, LLC 2
Sandhill Scientific offers a comprehensive selection of solid state and water perfused catheters for both adult & pediatric applications.Contact Sandhill Scientific for full details...
Sandhill Scientific offers a comprehensive selection of solid state and water perfused catheters for both adult & pediatric applications.Contact Sandhill Scientific for full details...
Sandhill Scientific offers a comprehensive selection of solid state and water perfused catheters for both adult & pediatric applications.Contact Sandhill Scientific for full details...
Sandhill Scientific offers a comprehensive selection of solid state and water perfused catheters for both adult & pediatric applications.Contact Sandhill Scientific for full details...
Medicine Products: